An antibody biomarker was recently discovered that identifies people with chronic skeletal muscle disease and severe heart muscle involvement.
Matters of the heart: a newly discovered type of inflammatory muscle disease with heart involvement
The Value of the Patient’s Perspective in Myositis Research
A survey of more than 600 people with myositis from the US, Korea, and Sweden identified 5 aspects of living with the disease that are most important to patients.
Muscle biopsy findings identify a unique subgroup of patients with severe Scleroderma
A new study found that people with scleroderma who have muscle weakness due to the accumulation of fibrous tissue in their muscles, are at risk for severe disease outcomes including death from heart disease.
Guidelines for Treating Arthritis Caused by New Cancer Therapies
A collaborative effort between Rheumatology and Oncology offers guidance to doctors treating patients for inflammatory arthritis caused by treatment with “immune checkpoint inhibitors”, a type of cancer therapy.
Hiker’s Feet: A new skin finding in patients with dermatomyositis
A study lead by Lisa Christopher-Stine, M.D., M.P.H. identified “Hiker’s Feet” as a new skin finding in some patients with inflammatory muscle disease (myositis).
The older the better, when it comes to anti-HMGCR associated myositis
Younger patients with a specific form of myositis associated with antibodies to a protein called HMGCR have a worse prognosis than older patients.
